Annual Drug Patent Expirations for FASLODEX Faslodex is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Astrazeneca drug FASLODEX appear…
New patent expiration for Astrazeneca drug FASLODEX Read Post »
Annual Drug Patent Expirations for XENLETA Xenleta is a drug marketed by Nabriva and is included in two NDAs. There are four patents protecting this drug. Drug patent litigation for…
The post New patent expiration for Nabriva drug XENLETA appeared firs…
Annual Drug Patent Expirations for MYCAMINE Mycamine is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent expiration for Astellas drug MYCAMINE appeared first …
New patent expiration for Astellas drug MYCAMINE Read Post »
FASLODEX (fulvestrant) Astrazeneca Patent: 7,456,160 Expiration: Jul 9, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug…
Drug Patent Expirations for the Week of July 4, 2021 Read Post »
Annual Drug Patent Expirations for NATROBA Natroba is a drug marketed by Parapro Llc and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Parapro Llc drug NATROBA appeared first on Dr…
New patent expiration for Parapro Llc drug NATROBA Read Post »
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. There are eleven patents protecting this drug. This drug…
The post New patent expiration for Paratek Pharms drug NUZYRA appeared firs…
New patent expiration for Paratek Pharms drug NUZYRA Read Post »
Annual Drug Patent Expirations for LIDOSITE+TOPICAL+SYSTEM+KIT Lidosite Topical System Kit is a drug marketed by Vyteris and is included in one NDA. There is one patent protecting this drug. This…
The post New patent expiration for Vyteris drug LIDOSIT…
New patent expiration for Vyteris drug LIDOSITE TOPICAL SYSTEM KIT Read Post »
Annual Drug Patent Expirations for BESIVANCE Besivance is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from two suppliers. There are five…
The post New patent expiration for Bausch And drug BESIVANCE appeared first on …
New patent expiration for Bausch And drug BESIVANCE Read Post »
SEEBRI (glycopyrrolate) Novartis Patent: 9,962,338 Expiration: Jun 27, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug …
Drug Patent Expirations for the Week of June 27, 2021 Read Post »
Annual Drug Patent Expirations for VYLEESI+%28AUTOINJECTOR%29 Vyleesi (autoinjector) is a drug marketed by Palatin Technologies and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Palatin Te…
New patent expiration for Palatin Technologies drug VYLEESI (AUTOINJECTOR) Read Post »